214. RASCHIG, F.: Berichte 48, 2088.

215. du NOUY, P. L.: Surface equilibria of biological and organic colloids.

Am. Chem. Soc. Monograph No. 27, New York, 1926.

du NOUY, P. L.: J. Gen. Physiol. 1:52, 1919.

216. ANDREAS, J. M., HAUSER, E. A., and TUCKER, W. B.: Boundary tension by pendant drops. J. Phys. Chem. 42:1001, 1938.

SMITH, G. W., and SORG, L. L.: Measurement of boundary tension by the pendant drop method. Phys. Chem. 45:671, 1941.

217. FEIGL, F.: Z. Analyt. Chem. 74:369, 1928.

218. BIER, M., and TEITELBAUM, P.: A new method for the determination of sulfhydryl levels and their variations in the blood of rats. Presented at the 126th Meeting, Am. Chem. Soc., New York, 1954.

219. RAVICH, R. A., and RAVICH, A.: Study of the urinary surface tension and protective colloids in urolithiasis: use of the Revici urotensiom eter. J. Urol. 72:1050, 1954.

220. REVICI, E.: Oxybiotic imbalances in biology. Role of lipids. Monaco Mediterranee Med. 8:1, 1941 (extra supplement). STOOPEN, E.: Action of fundamental lipids upon the reduction index of urine. Rev. Med. Pasteur 15:22, 1942.

OROZCO, C. F.: Relationship of the reduction index and other urine findings. Rev. Med. Pasteur 15:27, 1942.

221. REVICI, E., and LA BURT, H. A.: Observations on a new approach to the biological aspect of mental diseases. Abstract in 13th Ann. Report, Creedmoor State Hosp., 1948.

222. OROZCO, C. F.: The Revici reaction. Thesis, Univ. of Guadalajara, Mexico, 1943.

THEILER, R.: Concerning the Revici reaction in the urine. Thesis, Faculty of Medicine of Paris, 1940.

223. REVICI, E., HUESCA MEJIA, C, and RAVICH, R. A.: The measurement of the pH of experimentally produced wounds as a method for the study of abnormal foci. Bull. Inst. Appl. Biol. 1:73, 1949. REVICI, E.: The influence of irradiation upon unsaturated fatty acids. Presented at 6th International Congress of Radiology, London, July, 1950.

MAC INNNES, D. A., and DOLE, M.: Teste of a new type of glass electrode.J. Ind. & Eng. Chem., Anal. Ed. 1:57, 1929.

224. DUSSER de BARENNE, J. G., McCULLOUGH, W. S., and NIMS, L. F.: Functional activity and pH of the cerebral cortex. J. Cell, and Comp. Physiol. 10:277, 1937.

225. BLANK, I. H.: Measurement of pH of the skin surface, I. Technique. J. Invest. Derm. 2:67, 1939.

226. BLOOR, W. R.: Biochemistry of the fatty acids. Reinhold Publ. Co., New York, 1943.

227. MARIANI, J.: The Liposides: II. A study of their physico mathematical properties. Bull. Inst. Appl. Biol. 1:62, 1949.

228. FREY WYSSL1NG, A.: Submicroscopic Morphology of Protoplasm. Elsevier Co., New York, p. 206, 1953.

230. KARRER, P.: Organic Chem. Elsevier Co., New York, 1947.

231. TASKIER, E. F., REVICI, E., and WILLHE1M, R.: Measure of adrenal defense against various fatty acids. 136th Meeting, Am. Chem. Soc., Sept., 1959.

232. OPPENHEIMER, C: Chemische Grundlage der Lebensvorgange. Leipzig, 1933.

OPPENHEIMER, C: Handbuch Biochemie. Egan Zungwerk, Iona, 1933. THOMAS, P.: Manuel de Biochimie Masson. Paris, Chapter XXX, 1936.

233. QUICK, A. J.: J. Biol. Chem. 96, 1952. 235. QUICK, A. J.: J. Biol. Chem. 97, 1932.

QUICK, A. J.: J. Biol. Chem. 98, 1932.

237. REVICI, E., and RAVICH, R.: Surface tension of urine in old age. Geriatrics 9:386, 1954.

238. EBSTEIN, W.: Die Natur und Behandlung der Harnsteine. J. F. Bergmann, Wiesbaden, 1884.

239. JULY, J. S.: Stone and Calculous Disease of the Urinary Organs. C. V. Mosby, St. Louis, 1929.

240. BUTT, A. J.: Role of protective colloids in prevention of renal lithiasis.

J. Urol. 67:450. 1952.

241. BUTT, A. J., HAUSER, E. A., and SEIFTER, J.: Effect of hyaluronidase on urine and its possible significance in renal lithiasis. J. A. M. A. 150:1096, 1952.

242. BUTT, A. J., HAUSER, E. A., and SEIFTER, J.: Renal lithiasis: its treatment and prevention by increasing urinary colloids with hyaluronidase. Georgia J. M. A. 41:185, 1952.

243. REVICI, E.: Some general considerations of the role of lipids in blood physiology. Presented at the Gordon Research Conference, Kimball Academy, Meriden, New Hampshire, June, 1955.

244. REVICI, E.: Studies on paroxysmal hemoglobinuria. Rev. Med. Pasteur 15:12, 1942.

245. PILLEMER, L., BLUM, L., LEPOW, I. H., ROSS, O. A., TODD, E. W., and WARDLAW, A. C: The properdin system and immunity I.

Science 120:279, 1954. PILLEMER, L., BLUM, L., LEPOW, I. H., ROSS. O. A., TODD, E. W., and WARDLAW, A. G: The properdin system and immunity II.

Science 122:545, 1955. WILLHEIM, R., IVY, A. C, and JANECEK, H. M.: Cytolysis of Ehrlich ascites carcinoma cells by normal human blood sera. J. Exper. Med. Surg. 15:300. 1957.

246. WILLHEIM, R.: Lytic influence of serum on cancer cells. 7th Intern. Cancer Congress. London, 1958.

247. WILLHEIM. R., REVICI, E., and AUBER. M.: Further experiments concerning the lytic power of blood serum against ascites tumor cells. Fed. Proc. 18, No. 2374, 1959.

248. WILLHEIM, R., OMALLEY, B., and FLUSS, P.: Chemistry of carcinosis. 138th Meeting A. C. S., September, 1960.

250. ELKINTON, J. R., WINKLER, A. W., and DANOWSKI, T. S.: Transfer of cell sodium and potassium in experimental and clinical conditions. J. Clin. Invest. 21:1'4, 1948.

251. WINKLER, A. W., and SMITH, P. K.: Renal excretion of potassium salts. Am. J. Physiol. 138:94, 1942.

252. HOWARD, J. E.: The role of potassium in medical therapy. Conn. Med. J. 14:596, 1950.

253. DANOWSKI, T. S., PETERS, J. H., QUASHNOCK, J. M., and GREENMAN, L.: Studies in diabetic acidosis and coma, with particular emphasis on the retention of administered potassium. /. Clin. Invest. 28:1, 1949.

254. MOORE, F. D.: Adaptation of supportive treatment to needs of the surgical patient. J. A.M. A. 141:646, 1949.

255. FENN, W. O.: The role of potassium in physiological processes. Phys. Rev. 20:377, 1940.

256. ELKINTON, J. R., and WINKLER, A. W.: Transfer of intracellular potassium in experimental dehydration. J. Clin. Invest. 23:93, 1944.

257. RANDALL, H. T., HABIF, D. V., LOCKWOOD, J. S., and WERNER, S. C: Potassium deficiency in surgical patients. Surg. 26:341, 1949.

258. GASS, H., CHERKASKY, M.. and SAVITSKY, N.: Potassium and periodic paralysis. A metabolic study and physiological considerations. Medicine 27:105. 1948.

259. MERRILL, J. P., LEVINE, W. D., SOMERVILLE, W., and SMITH, S. 3rd: Clinical recognition and treatment of acute potassium intoxication. Am. Int. Med. 33:797, 1950.

260. FINCH, C. A., SAWYER, C. G., and GLYN, J. M.: Clinical syndrome of potassium intoxication. Am. J. Med. 1:337, 1946.

261. MC NAUGHTON. R. A., and BURCHELL, H. B.: Paralysis with potassium intoxication in renal insufficiency.J. A. M. A. 195:481, 1951.

262. WINKLER, A. W., HOFF, H. E., and SMITH, P. K.: Electrocardiographic changes and concentration of potassium in serum following injection of potassium chloride. Am. J. Physiol. 124:478, 1938.

263. TARAIL, R.: Relationship of abnormalities in concentration of serum potassium to electrocardiographic disturbances. Am. J. Med. 5:828, 1948.

265. SHOHL, A. R.: Mineral Metabolism. Reinhold Publ. Co., New York. p. 35 and 121, 1939.

266. WURTZ'S Chem. Die.

267. ANDRE, A.: J. Chem. Physiology 15:242, 1925.

268. HENRIET, H.: Sur l'acide formique atmospherique. C. R. Ac. Sc. 136:- 1465, 1903.

269. LOEW, W.: Ber Dtsch. chem. Grs. 46:687, 1913.

270. MILLER, S. L.: Production of amino acids under possible primitive earth conditions. Science 117:528, 1953.

271. MILLER, S. L.: J. Am. Chem. Soc. 77:2351, 1955.

272. ABELSON, P. H.: Amino acid formed in "primitive atmosphere." Science 124:935, 1956.

273. MILLER, S. L.: The mechanism of synthesis of amino acids by electric discharges. Bioch. Biophys. Acta 23:480, 1957.

274. MILLER, S. L.: The formation of organic compounds on the primitive earth. Ann. N. Y. Acad. Sci. 69:260, 1957.

275. GROTH, W., and WEYSSENHOFF, H. V.: Photochemical formation of amino acids from mixture of simple gases. Naturwiss 44:510, 1952. (Ch. Ab. 5140)

276. HEYNS, K., WALTER, W., and MEYER, .: Experiments on the formation of organic compounds by electric discharges in atmospheres of simple gases. Naturwiss 44:385, 1957. (Ch. Ab. 52, 5140)

277. DOSE, K., and RAJEWSKY, B.: Strahlenchemische Bildung von Aminen und Aminocarbonsauren. Bioch. Biophys. Acta 25:225, 1957.

278. OPARIN, J.: Origin of Life. Acad. Press, 1958.

279. PAVLOSKAYA, T. E., and PASSYNSKY, A. G.: Amino acid formation when exposing formaldehyde and ammonium salt solutions to ultraviolet irradiations. IV Cong. Int. Bioch. 12, Vienna, 1958.

280. GARRISON, N. M., MORRISON, D. C, HAMILTON, J. G., BRUSON, A. A., and CALVIN, M.: Reduction of carbon dioxide in aqueous solution by ionizing radiations. Science 114:416, 1951.

281. MILLER, S. L., and UREY, N. C: Organic compound synthesis on the primitive earth. Science 130:245, 1959.

282. GROTH, N., and WEYSSENHOFF, H. V.: Photochemische Bildung organischer Verbindungen aus Mischungen einfacher gase.

283. HASSELFROM, T., HENRY, M. C. and MURR, B.: Synthesis of amino acids by I radiation. Science 125:350, 1957.

284. PASCHKE, R., CHANG, R., and YOUNG, D.: Probable role of gamma irradiation in the origin of life. Science 125:881, 1957.

285. FOX, S. W.: Origin of life. Science 130:1622, 1959.

286. FOX, S. N., HARADA, K., and VEGOTSKY, A.: Thermal polymerization of amino acids and a theory of biochemical origins. Experimentia 15:81, 1959.

287. GRUNDLAND, L.: Origines de la vie. Experimentia 15:239. 1959. 289. HART, R. G., and SMITH, J. D.: Interactions of ribonucleotide polymers with tobacco mosaic virus protein to form virus like particles. Nature 178:739, 1956.

289. FRAENKEL CONRAT, H.: The role of nucleic acid in the reconstitution of active tobacco mosaic virus.J. Amer. Chem. Soc. 78:882, 1956. GIERER, A.: Structure and biological function of ribonucleic acid from tobacco mosaic virus. Nature 179:297, 1957. GIERER, A., and SCHRAMM, G: Infectivity of ribonucleic acid from tobacco mosaic virus. Nature 177:702, 1956. GINOZA, W., and NORMAL, A.: Radiosensitive molecular weight of tobacco mosaic virus nucleic acid. Nature 179:52, 1957. ANONYMOUS: Viruses made to order. Brit. Med. J. No. 5015:390, 1957.

290. ARM IT AGE, P., and DOLL, R.: The age distribution of cancer and a multi stage theory of carcinogenesis. Brit. J. Cancer 8:1, 1954. ARMITAGE, P., and DOLL, R.: A two stage theory of carcinogenesis in relation to the age distribution of human cancer. Brit. J. Cancer 11:161, 1957.

291. BEDGER, G. M.: Chemical constitution and carcinogenic activity. Advanc. Cancer Res. 2:73. 1954. BARNES, A. D., and KROHN, P. L.: The estimation of the number of histocompatibility genes controlling the successful transplantation of normal skin in mice. Proc. Roy. Soc. B. 146:505, 1957.

293. BAWDEN, F. C, and PIR1E, N. W.: Physiology of virus diseases. Ann. Rev. PI. Physiol. 3:171, 1952. ECKERT, E. A., SHARP, D. G., BEARD, D., and BEARD, J. W.: Variation in infectivity and virus particle content. J. Nat. Cancer Inst. 13:533, 1952. BEARD, J. W., SHARP, D. G., and ECKERT, E. A.: Tumor viruses.

Advanc. Virus Res. 3:149, 1955.

294. BENEDETTI, E. L., and BERNHARD, W.: Presence de particules d'aspect virusal dans la rate d'embryons de poulets normaux. C. R. Ac. Sc. 244:2204, 1957.

295. BERENBLUM, I.: A speculative review: the probable nature of promoting action. Cancer Res. 14:471, 1954. BERENBLUM, I.: Circumstantial evidence pointing to differences between cancers in terms of etiologic factors. Cancer Res. 16:675, 1956.

296. BERR1LL, N. J.: Malignancy in relation to organization and differentiation. Physiol. Rev. 23:101, 1943.

297. BROWNING, H.: The action of tumors on normal tissue. Cancer Res. 12:13, 1952.

298. CAIRNS, H. J. F., and WATSON, G. S.: Multiplicity reactivation of bacteriophages. Nature 177:131, 1956.

299. CARR, J. G.: The mode of multiplication of the Rous no. 1 sarcoma virus. Proc. Roy. Soc. Edinb. 65:66, 1953.

300. COMFORT, A.: The Biology of Senescence. London, 1954.

301. CRICK, F. H. C, and WATSON, J. D.: Structure of small viruses.

Nature 177:473, 1956.

302. DALE, R. C: Cellular adhesiveness in relation to the invasiveness of cancer. Cancer Res. 14:519, 1954.

303. FEDOTOV, M.: Russian work on chemical induction. Nature 158:367, 1949.

304. FORD, E. B.: Genetics and cancer. Heredity 3:251, 1949.

305. GARDNER, W. V.: Studies on steroid hormones in experimental cancer.

Rec. Progr. Hormone Res. 1:217, 1947.

306. GREENSTEIN, J. P.: Biochemistry of Cancer. New York, 1954.

307. HAUSCHKA, T. S.: Immunologic aspects of cancer: a review. Cancer Res. 12:615, 1952.

308. KALISS, N., and MOLOMUT, N.: The effect of prior injections of tissue antiserums. Cancer Res. 12:110, 1952.

309. LEV AN, A.: Chromosomes in cancer tissue. Ann. N. Y. Acad. Sci. 63:774, 1956.

310. LURIA, S. E.: Mechanism of bacteriophage reproduction. Fed. Proc. 10:582, 1951.

311. MENKIN, V.: Biology of inflammation. Science 123:527, 1956. MENKIN, V.: Studies on the possible induction of precancerous lesions by a fraction derived from inflammatory exudates. Proc. Amer. Assn. Cancer Res. 2:2, 1956.

MENKIN, V.: Biological Mechanisms in Inflammation. Thomas, Springfield, Chapt. 8, 1956.

MENKIN, V.: Growth promoting factor of exudates and pre neoplastic responses. Proc. Amer. Assn. Cancer Res. 2:3, 1957.

312. RUBIN, H.: Quantitative relations between causative virus and cell in the Rous no. 1 chicken sarcoma. Virology 1:445, 1955. RUBIN, H.: Immunological relationships between virus and cell in the Rous sarcoma. Ann. N. Y. Acad. Sci. 69:4, 1957.

313. STACEY, M.: Chemistry of the gram staining process. Nature 176:1145, 1955.

314. TANNENBAUM, A.: The dependence of tumor formation on the degree of caloric restriction. Cancer Res. 5:609, 1945.

315. SOUTHAM, C. M., MOORE, A. E., and RHOADS, C. P.: Homotransplantation of human cell lines. Science 125:158, 1957.

316. DOMAGK, G.: Histologische Veranderungen an experimentellen und menschlichen Tumoren nach Darreichung von Zytostatika. Deut. Med. Woch. 21:81, 1956.

317. HALBERG, F.: Some physiological and chemical aspects of 24 hrs. periodicity. Lancet 73:20, 1953.

318. WERTLAKE, P. T., WILCOX, A. A., HALEY, M. I., and PETERSON, J. E.: Variation on serum lipids during mental and emotional stress. Am. Heart Assoc. Mtng. Oct., 1958.

319. AYLWARD, F.: Excretion of cholesterol. Lancet. October, 1958.

320. KINSELL, L. W., MICHAEL. G. D., FRISKEY, R. W., and SPLITTER, S.: Essential fatty acids, lipid metabolism and atherosclerosis. Lancet. Feb., 1958.

321. MOLMROS, H., and WIGAND, G.: Atherosclerosis and deficiency of essential fatty acids. Lancet. Nov. 7, 1959.

322. AHRENS, E. H., INSULL, W., HIRSCH, J., STOFFEL, W., PETERSON, M., FARQUHAR, J., MILLER, T., and THOMASSON. H.: The effect on human serum lipids of a dietary fat, highly unsaturated but poor in essential fatty acids. Lancet. Jan. 17, 1959.

323. NOTHMAN, M., and PROGER, S.: On the effect of arachidonic acid on serum lipids in man. Fed. Proc. 19:Part 1, 1960.

324. RAVICH, A., and RAVICH, A. R.: Prophylaxis of cancer of the prostate, penis, and cervix by circumcision. N. Y. State J. of Med. 51: 1519, 1951. RAVICH, A.: 7. Urol. 48:298, 1942.

325. BARON, E., and ANGRIST, A.: Arch. Path. 32:787, 1941.

326. REVICI, E.: The role of biological imbalances in physiopathology and therapy. Rev. Med. Pasteur, 15:133, 1942.

327. GOLDMAN, L. B.: Use of lipids to enhance the effect of roentgen therapy in the treatment of pain from advanced cancer. Presented before Amer. Medical Association, Section of Radiology, Atlantic City. June 14, 1951.